These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11806807)

  • 1. Comments on ALLHAT and doxazosin.
    Krakoff LR
    Curr Control Trials Cardiovasc Med; 2001; 2(6):254-256. PubMed ID: 11806807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Pressel SL; Davis BR; Wright JT; Geraci TS; Kingry C; Ford CE; Piller LB; Bettencourt J; Kimmel B; Lusk C; Parks H; Simpson LM; Nwachuku C; Furberg CD;
    Control Clin Trials; 2001 Feb; 22(1):29-41. PubMed ID: 11165421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.
    Davis BR; Cutler JA; Gordon DJ; Furberg CD; Wright JT; Cushman WC; Grimm RH; LaRosa J; Whelton PK; Perry HM; Alderman MH; Ford CE; Oparil S; Francis C; Proschan M; Pressel S; Black HR; Hawkins CM
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):342-60. PubMed ID: 8722437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
    Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR;
    Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone.
    Piller LB; Davis BR; Cutler JA; Cushman WC; Wright JT; Williamson JD; Leenen FH; Einhorn PT; Randall OS; Golden JS; Haywood LJ;
    Curr Control Trials Cardiovasc Med; 2002 Nov; 3(1):10. PubMed ID: 12459039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
    Hypertension; 2003 Sep; 42(3):239-46. PubMed ID: 12925554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
    J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxazosin and congestive heart failure.
    Sica DA
    Congest Heart Fail; 2002; 8(3):178-84. PubMed ID: 12045387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Grimm RH; Margolis KL; Papademetriou V; Cushman WC; Ford CE; Bettencourt J; Alderman MH; Basile JN; Black HR; DeQuattro V; Eckfeldt J; Hawkins CM; Perry HM; Proschan M
    Hypertension; 2001 Jan; 37(1):19-27. PubMed ID: 11208751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization.
    Xie F; Petitti DB; Chen W
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):464-9. PubMed ID: 15831354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Pressel S; Davis BR; Louis GT; Whelton P; Adrogue H; Egan D; Farber M; Payne G; Probstfield J; Ward H;
    Control Clin Trials; 2001 Dec; 22(6):674-86. PubMed ID: 11738123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.
    Furberg CD; Psaty BM; Pahor M; Alderman MH
    Ann Intern Med; 2001 Dec; 135(12):1074-8. PubMed ID: 11747386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
    Davis BR; Kostis JB; Simpson LM; Black HR; Cushman WC; Einhorn PT; Farber MA; Ford CE; Levy D; Massie BM; Nawaz S;
    Circulation; 2008 Nov; 118(22):2259-67. PubMed ID: 19001024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Jones CL; Davis BR; Basile JN; Goff DC; Ciocon JO; Sweeney ME; Randall OS;
    Diabetes Care; 2001 Apr; 24(4):654-8. PubMed ID: 11315826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxazosin and congestive heart failure.
    Messerli FH
    J Am Coll Cardiol; 2001 Nov; 38(5):1295-6. PubMed ID: 11691497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study.
    Barzilay JI; Davis BR; Bettencourt J; Margolis KL; Goff DC; Black H; Habib G; Ellsworth A; Force RW; Wiegmann T; Ciocon JO; Basile JN;
    J Clin Hypertens (Greenwich); 2004 Mar; 6(3):116-25. PubMed ID: 15010644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study.
    Johnson K; Oparil S; Davis BR; Tereshchenko LG
    J Am Heart Assoc; 2019 Apr; 8(8):e011961. PubMed ID: 30943832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-blockers and congestive heart failure: early termination of an arm of the ALLHAT trial.
    Vidt DG
    Cleve Clin J Med; 2000 Jun; 67(6):429-33. PubMed ID: 10860225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretics vs alpha-blockers for treatment of hypertension: lessons from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Lasagna L
    JAMA; 2000 Apr; 283(15):2013-4. PubMed ID: 10789671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.